Abstract
A prospective study was conducted from February 1989 to January 1991, on 5,000 consecutive patients, undergoing CT studies of the head and brain, to evaluate the adverse reactions to sodium meglumine ioxithalamate, a high-osmolar contrast medium (HOCM). The overall incidence of moderate or severe reactions was 2.8%. Severe reactions occurred in 0.06% and moderate reactions in 2.74% of the contrast media examinations. It is interesting to note that the risk of adverse reactions was multiplied by 7.6 in patients with the acquired immune deficiency syndrome (AIDS). No deaths occured. It is concluded that the incidence of adverse reactions to Ioxithalamate is low. Although the occurrence of adverse reactions is lower with low osmolar contrast media (LOCM), the routine use of HOCM appears justified by the best cost-efficacy ratio in low-risk patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kinninson ML, Powe NR, Steinberg ER (1989) Results of randomized controlled trials of low versus high-osmolality contrast media. Radiology 170: 381–389
Gertsman B (1991) Epidemiologic critique of the report on adverse reactions to ionic and non-ionic media by the Japanese committee on the safety of contrast media. Radiology 178: 787–790
Amiel M (1990) Actualité des produits de contraste uroangiographiques. Rev Im Med 2: 145–150
Bidabé AM, Caillé JM (1985) Effects secondaires des produits de contraste iodés. prévention et traitement. Feuillets de Radiologie 25: 313–320
Keats AS (1978) The ASA classifications of physical status. A recapitulation. Anesthesiology 49: 233–236
Ansell G, Tweedie MCK, West CR, Price Evans DA, Couch L (1990) The current status of reactions to intravenous contrast media. Invest Radiol 15 [Suppl]: S32–39
Shehadi WH (1982) Contrast media adverse reactions: occurence, recurrence and distribution patterns. Radiology 143: 11–17
Wolf GL, Arenson RL, Cross AP (1989) A prospective trial of ionic versus non-ionic contrast agents in routine clinical practice: comparison of adverse effects. AJR 152: 939–944
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K (1990) Adverse reactions to ionic and non-ionic contrast media. Radiology 175: 621–628
Jaffe HS, Abrams DI, Amman AJ, Lewis BJ, Golden JA (1983) Complications of co-trimoxazole in the treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet: 1109–1111
Gordin FM, Simon GL, Wofsy CB, Mills J (1984) Adverse reactions to trimethoprim-sulfametoxazole in patients with the acquired immunodeficiency syndrome. Ann Int Med 100: 495–499
Van der Ven A, Koopmans P, Vree T, Van der Meer J (1991) Adverse reactions to co-trimoxazole in HIV infection. Lancet 338: 431–433
Gardeur D, Lautrou J, Millard JC, Berger N, Metzger J (1980) Pharmacokinetics of contrast media: experimental results in dog and man with CT implications. J Comput Assist Tomogr 4: 178–185
Wright DN, Nelson RP, Ledford DK, Fernandez-Caldas E, Trudeau WL (1990) Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 85: 445–452
Author information
Authors and Affiliations
Additional information
Correspondence to: A.-M. Bidabé
Rights and permissions
About this article
Cite this article
Bidabé, AM., Dartigues, JF., Dousset, V. et al. Incidence and risk factors of adverse reactions to ioxithalamate in patients with computed tomography. Eur. Radiol. 3, 459–462 (1993). https://doi.org/10.1007/BF00221424
Issue Date:
DOI: https://doi.org/10.1007/BF00221424